The Mayo AL staging systems incorporate troponin T, NT pro-BNP, and more recently serum immunoglobulin FLCs.15, 16 Unlike MM which relies heavily on cytogenetic aberrations for risk stratification, until recently there were not any established cytogenetic prognostic markers for AL. This evidence concerns the gene NPPB and axial length measurement.